Popular sugar substitutes linked to faster brain aging, study suggests
Millions of people looking to cut back on sugar reach for artificial sweeteners like aspartame, sucralose, or saccharin as part of their daily routine. But a newly published study suggests that choice may carry an unexpected cost: researchers observed faster cognitive decline among participants who consumed high levels of artificial sweeteners.
The study followed participants over several years, tracking both their sweetener consumption habits and their performance on cognitive tests measuring memory, attention, and processing speed. Researchers found that the group with the highest sweetener consumption showed a more pronounced decline on those tests compared with the lowest-consumption group.
Scientists are careful to note that observational studies like this one cannot prove causation. People who consume high levels of artificial sweeteners may, for instance, also eat more processed food or have underlying metabolic conditions — confounding factors that could obscure the real driver behind the observed link.
Still, researchers say the association was strong and consistent enough that it's unlikely to be pure coincidence. Some animal studies have suggested that certain sweeteners can alter gut microbiota, and that shift may connect to inflammatory pathways that affect brain function — offering a plausible biological explanation for the pattern observed in people.
The study doesn't treat all sweeteners the same. Some types were linked to a stronger association than others, suggesting the effect may depend on a sweetener's specific chemical structure. Researchers say more detailed work is needed to pin down which compounds actually carry risk.
Nutrition experts say the findings shouldn't push people to panic and cut sweeteners entirely, but rather toward moderate consumption. It's worth remembering that sugar itself is strongly linked to obesity, type 2 diabetes, and heart disease — so switching back from sweeteners to sugar isn't automatically the healthier choice.
The study's authors say their findings aren't yet enough to change clinical guidance, but the issue deserves to be taken seriously — particularly for people who consume multiple diet drinks or "sugar-free" products daily, where understanding long-term effects matters most.
Scientists say future research needs to be backed by randomized controlled trials — studies where participants are randomly assigned to sweetener-consuming and non-consuming groups, allowing confounding factors to be controlled far more rigorously. Such trials are more expensive and take longer, but they can offer a far more reliable answer to the causation question.
In the meantime, public health experts are trying to strike a balanced message: sweeteners aren't a magic, entirely risk-free replacement for sugar, but the current evidence also isn't conclusive enough to justify abandoning them altogether. Moderate consumption is still considered a reasonable approach.
Ultimately, the study joins a growing body of research questioning the image of artificial sweeteners as an automatically "safe, sugar-free" choice. When it comes to brain health, at least for now, the answer isn't a simple yes or no — it's a question mark that warrants closer, ongoing scrutiny.
Read next
Second death reported in New York City legionnaires' disease outbreak
A second person has died in a legionnaires' disease outbreak that has sickened dozens of people in New York City, health officials say, even as they report evidence the source of the bacteria has likely been eliminated.
A common antidepressant may ease long COVID's crushing fatigue, trial finds
A randomized clinical trial of nearly 400 adults found that fluvoxamine, a low-cost, decades-old antidepressant, significantly reduced fatigue and improved quality of life in people with long COVID, making it one of the first medications to show a meaningful benefit for the debilitating symptom.
Mineral sunscreen without the chalky white cast: what UCLA's new formula changes
Mineral sunscreens are prized for being gentler on skin than chemical alternatives, but they have long left users with a visible white cast. Scientists at UCLA say they have redesigned the zinc oxide particles at the heart of the problem, aiming to make mineral sunscreen usable across all skin tones.
Menopause hormone therapy: what it actually treats, and what it doesn't
Menopause hormone therapy has swung from being widely feared to widely recommended, but doctors say expectations have overtaken the evidence. Here is what the treatment reliably helps with, what it doesn't, and how the science has shifted over two decades.
FDA still points to Taylor Farms lettuce in cyclospora outbreak despite a faulty test
US regulators say they remain focused on lettuce supplied by Taylor Farms as the likely source of a multistate cyclospora outbreak, even after one laboratory test used to support that theory turned out to be faulty. Restaurant visits tied to the outbreak have started to decline.